{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T17:40:05Z","timestamp":1716658805531},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2004,7,1]],"date-time":"2004-07-01T00:00:00Z","timestamp":1088640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2004,7]]},"DOI":"10.1007\/bf03347496","type":"journal-article","created":{"date-parts":[[2014,4,4]],"date-time":"2014-04-04T12:30:53Z","timestamp":1396614653000},"page":"643-647","source":"Crossref","is-referenced-by-count":2,"title":["Serum prostate-specific antigen concentration is increased in acromegalic women"],"prefix":"10.1007","volume":"27","author":[{"given":"L.","family":"Manetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Lupi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Genovesi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Morselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Nencetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Gasperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Bogazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bartalena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,4,2]]},"reference":[{"key":"BF03347496_CR1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1210\/edrv-10-4-393","volume":"10","author":"JA Clements","year":"1989","unstructured":"Clements JA. The glandular kallicrein family of enzymes: tissue-specific expression and hormonal regulation. Endocr Rev 1989, 10: 393\u2013419.","journal-title":"Endocr Rev"},{"key":"BF03347496_CR2","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0090-4295(99)80076-4","volume":"45","author":"RT McCormack","year":"1995","unstructured":"McCormack RT, Rittenhouse HG, Finlay JA, et al. Molecular forms of prostate specific antigen and the human kallicrein gene family: a new era. Urology 1995, 45: 729\u201344.","journal-title":"Urology"},{"key":"BF03347496_CR3","first-page":"159","volume":"17","author":"MC Wang","year":"1979","unstructured":"Wang MC, Valenzuele LA, Murphy GP, Chu TM. Purification of human prostate specific antigen. Invest Urol 1979, 17: 159\u201363.","journal-title":"Invest Urol"},{"key":"BF03347496_CR4","first-page":"2428","volume":"40","author":"LD Papsidero","year":"1980","unstructured":"Papsidero LD, Wang MC, Valenzuela LA, Murphy GP, Chu TM. A prostate antigen in sera of prostatic cancer patients. Cancer Res 1980, 40: 2428\u201332.","journal-title":"Cancer Res"},{"key":"BF03347496_CR5","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1056\/NEJM199104253241702","volume":"324","author":"WJ Catalona","year":"1991","unstructured":"Catalona WJ, Smith DS, Ratliff TL, et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer. N Engl J Med 1991, 324: 1156\u201361.","journal-title":"N Engl J Med"},{"key":"BF03347496_CR6","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1210\/jcem.80.5.7538144","volume":"80","author":"EP Diamandis","year":"1995","unstructured":"Diamandis EP, Yu H. New biological functions of prostate specific antigen? J Clin Endocrinol Metab 1995, 80: 1515\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0094-0143(05)70373-6","volume":"24","author":"EP Diamandis","year":"1997","unstructured":"Diamandis EP, Yu H. Nonprostatic sources of prostate-specific antigen. Urol Clin North Am 1997, 24: 275\u201382.","journal-title":"Urol Clin North Am"},{"key":"BF03347496_CR8","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0022-5347(01)67622-5","volume":"153","author":"H Yu","year":"1995","unstructured":"Yu H, Diamandis EP. Measurement of serum prostate specific antigen levels in females and in prostatectomized males with an ultrasensitive immunoassay technique. J Urol 1995, 153: 1004\u20138.","journal-title":"J Urol"},{"key":"BF03347496_CR9","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/clinchem\/42.6.853","volume":"42","author":"EP Diamandis","year":"1996","unstructured":"Diamandis EP, Yu H, Melegos DN. Ultrasensitive prostate specific antigen assays and their clinical application. Clin Chem 1996, 42: 853\u20137.","journal-title":"Clin Chem"},{"key":"BF03347496_CR10","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1210\/jcem.82.3.3792","volume":"82","author":"DN Melegos","year":"1997","unstructured":"Melegos DN, Yu H, Ashok M, Wang C, Stanczyk F, Diamandis EP. Prostate-specific antigen in female serum, a potential new marker of androgen excess. J Clin Endocrinol Metab 1997, 82: 777\u201380.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR11","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1210\/jcem.83.7.4960","volume":"83","author":"HF Escobar-Morreale","year":"1998","unstructured":"Escobar-Morreale HF, Serrano-Gotarredona J, Avila S, Villar-Palas\u00ec J, Varela C, Sancho J. The increased circulating prostate-specific antigen concentrations in women with hirsutism do not respond to acute changes in adrenal or ovarian function. J Clin Endocrinol Metab 1998, 83: 2580\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR12","first-page":"81","volume":"85","author":"C Negri","year":"2000","unstructured":"Negri C, Tosi F, Dorizzi R, et al. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women. J Clin Endocrinol Metab 2000, 85: 81\u20134.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR13","first-page":"2488","volume":"85","author":"HF Escobar-Morreale","year":"2000","unstructured":"Escobar-Morreale HF, Avila S, Sancho J. Serum prostatespecific antigen concentrations are not useful for monitoring the treatment of hirsutism with oral contraceptive pills. J Clin Endocrinol Metab 2000, 85: 2488\u201392.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF03345504","volume":"25","author":"L Manetti","year":"2002","unstructured":"Manetti L, Lupi I, Bogazzi F, et al. Prostate-specific antigen is increased in female patients with Cushing\u2019s disease. J Endocrinol Invest 2002, 25: 29\u201331.","journal-title":"J Endocrinol Invest"},{"key":"BF03347496_CR15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/endo-123-2-733","volume":"123","author":"JF Cara","year":"1988","unstructured":"Cara JF, Rosenfield RL. Insulin-like growth factor I and insulin potentiating luteinizing hormone-induced androgen synthesis by rat ovarian thecalinterstizial cells. Endocrinology 1988, 123: 733\u20139.","journal-title":"Endocrinology"},{"key":"BF03347496_CR16","first-page":"774","volume":"18","author":"A Dunaif","year":"1997","unstructured":"Dunaif A. Insulin resistance and the polycistic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev 1997, 18: 774\u2013800.","journal-title":"Endocr Rev"},{"key":"BF03347496_CR17","first-page":"48","volume":"26","author":"JAH Wass","year":"2003","unstructured":"Wass JAH. Dynamic testing in the diagnosis and followup of patients with acromegaly. J Endocrinol Invest 2003, 26: 48\u201353.","journal-title":"J Endocrinol Invest"},{"key":"BF03347496_CR18","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/j.1939-4640.1994.tb01682.x","volume":"15","author":"MC Luke","year":"1994","unstructured":"Luke MC, Coffey DS. Human androgen receptors binding to the androgen response element of prostate specific antigen. J Androl 1994, 15: 41\u201351.","journal-title":"J Androl"},{"key":"BF03347496_CR19","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1210\/er.2001-0031","volume":"24","author":"F Labrie","year":"2003","unstructured":"Labrie F, Luu-The V, Labrie C, et al. Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiadrosterone. Endocr Rev 2003, 24: 152\u201382.","journal-title":"Endocr Rev"},{"key":"BF03347496_CR20","first-page":"2001","volume":"83","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, de Vargas AF, Brik C, Quintero N, Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 1998, 83: 2001\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/edrv-12-1-3","volume":"12","author":"L Poretsky","year":"1991","unstructured":"Poretsky L. On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 1991, 12: 3\u201313.","journal-title":"Endocr Rev"},{"key":"BF03347496_CR22","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1210\/jcem.83.3.4645","volume":"83","author":"A Colao","year":"1998","unstructured":"Colao A, Marzullo P, Ferone D, et al. Prostatic hyperplasia: an unknown feature of acromegaly. J Clin Endocrinol Metab 1998, 83: 775\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR23","first-page":"12181","volume":"272","author":"R Rajah","year":"1997","unstructured":"Rajah R, Valetinis B, Cohen P. Insulin-like growth factor-I and-II in human benign prostatic hyperplasia: relationship with binding proteins 2 and 3 and androgens. Steroids 1997, 272: 12181\u20138.","journal-title":"Steroids"},{"key":"BF03347496_CR24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF03349988","volume":"12","author":"A Barreca","year":"1989","unstructured":"Barreca A, Minuto F. Somatomedins: chemical and functional characteristics of the different molecular forms. J Endocrinol Invest 1989, 12: 279\u201394.","journal-title":"J Endocrinol Invest"},{"key":"BF03347496_CR25","first-page":"3","volume":"16","author":"JI Jones","year":"1995","unstructured":"Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995, 16: 3\u201334.","journal-title":"Endocr Rev"},{"key":"BF03347496_CR26","first-page":"1046","volume":"75","author":"P Cohen","year":"1992","unstructured":"Cohen P, Graves HC, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulinlike growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992, 75: 1046\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR27","first-page":"618","volume":"81","author":"SR Plymate","year":"1996","unstructured":"Plymate SR, Rosen CJ, Paulsen CA, et al. Proteolysis of insulin-like growth factor-binding protein-3 in the male reproductive tract. J Clin Endocrinol Metab 1996, 81: 618\u201324.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03347496_CR28","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000474724","volume":"22","author":"N Wernert","year":"1992","unstructured":"Wernert N, Albrech M, Sesterhenn I, et al. The \u201cfemale prostate\u201d. Location, morphology, immunohistochemical characteristics and significance. Eur Urol 1992, 22: 64\u20139.","journal-title":"Eur Urol"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347496.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03347496\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03347496","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T17:13:52Z","timestamp":1716657232000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03347496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["BF03347496"],"URL":"https:\/\/doi.org\/10.1007\/bf03347496","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]}}}